vaccine

AstraZeneca and Johnson & Johnson announced Friday that they would resume their phase 3 clinical trials on COVID-19 vaccine candidates in the U.S, NBC News reports.

As scientists race to release a safe COVID-19 vaccine, a new study shows 57% of Californians would likely take a COVID-19 vaccine if it were available today. NBC 7 checked in with a handful of people, at random, who shared the same opinions as those in the study, when categorized by race or ethnicity. The study conducted by the Public…

A UCLA pediatrician and researcher named to a new state panel to review FDA-approved coronavirus vaccines said Wednesday that if COVID-19 mutates into something deadlier, people may be getting vaccinated against the respiratory disease each year — along the lines of seasonal flu inoculations.

AstraZeneca shares turned negative Wednesday after a Brazilian health authority, Anvisa, said a volunteer in its coronavirus vaccine study died.

Moderna’s coronavirus vaccine could be ready by the end of the year – if it’s proven safe.

Companies and governments around the world are testing at least 120 potential vaccines for COVID-19. One of the test subjects is a local scientist.

While the symptoms were uncomfortable, and at times intense, they often went away after a day, sometimes less, some participants said.

The federal government is outlining a sweeping plan to make COVID-19 vaccines available for free to all Americans

Centers for Disease Control and Prevention Director Robert Redfield testified on Wednesday that broad access to the COVID-19 vaccination likely won’t be available until “the second or third quarter” of 2021.

A drugmaker says it halted a coronavirus vaccine study because a woman who received the experimental shot developed severe neurological symptoms

AstraZeneca announced late Tuesday that it is pausing its crucial late-stage trial for its coronavirus vaccine candidate as a result of a patient illness. This comes a day after several companies signed a safety pledge to uphold the scientific standards that their experimental vaccines will be held against.

With the pharmaceutical industry fast-tracking a Covid-19 vaccine, some have questioned whether the public can trust that it is safe. But Former FDA Associate Commissioner Peter Pitts says people can rely on the scientific community to approve a vaccine that can be trusted.

The delivery of any future coronavirus vaccine requires “careful planning” with the air transport industry now in order to avoid “potentially severe” issues when it’s ready for global distribution, the International Air Transport Association (IATA) has warned.

AstraZeneca shares fell more than 6% in after-hours trading Tuesday after the company said its late-stage trial for a potential coronavirus vaccine had been put on hold due to safety concerns.

In the more than eight months since the novel coronavirus emerged and then spread around the world, scientists across the globe have made rapid progress on developing a COVID-19 vaccine. As of Sept. 3, at least 176 vaccines are in the works, with nearly three dozen already in clinical trials, according to the World Health Organization. But until a vaccine is...

Could the U.S. really see a coronavirus vaccine before Election Day

UC San Diego Health announced Wednesday it will join a second, national clinical trial to develop a vaccine designed to protect against SARS-CoV-2, the novel coronavirus that causes COVID-19, by the end of the year.

Public health departments, which have struggled for months to test and trace everyone exposed to the novel coronavirus, are now being told to prepare to distribute COVID-19 vaccines as early as Nov. 1

The U.S. Centers for Disease Control and Prevention is asking states to expedite the approval process for medical supply company McKesson so it can set up coronavirus vaccination sites by Nov. 1, CNBC has confirmed.

NIAID Director Dr. Anthony Fauci says he expects the U.S. to have one or more successful vaccine candidates.